MBS635137 | TAFI, Human (Thrombin Activatable Fibrinolysis Inhibitor)

TAFI, Human (Thrombin Activatable Fibrinolysis Inhibitor) | MBS635137 | MyBiosource

Product Short Name: [TAFI]

Product Name Synonyme: N/A

Other Names: [thrombin-activatable fibrinolysis inhibitor; Carboxypeptidase B2; carboxypeptidase B2; carboxypeptidase R; carboxypeptidase U; thrombin-activable fibrinolysis inhibitor; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase B2 (plasma); Carboxypeptidase R; CPR; Carboxypeptidase U; CPU; Thrombin-activable fibrinolysis inhibitor]

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: [Cpb2; Cpb2; CPR; Cpu; TAFI; AI255929; 1110032P04Rik; 4930405E17Rik; Tafi; CPR; CPU; TAFI]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: N/A

Reactivity: N/A

Specificity: N/A

Purity: Purified
90% pure (SDS-PAGE)

Form: Supplied as a lyophilized powder from 10mM Tris-HCl, 0.15M Sodium chloride, pH 7.5. Reconstitute in distilled water.

Concentration: N/A

Storage Stability: Lyophilized powder may be stored at -20 degree C. Reconstitute with sterile buffer or ddH2O. Aliquot and store at -20 degree C. Reconstituted product is stable for 6 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Tested Application: N/A